Hoping to learn what other institutions are doing to mitigate insulin adsorption concerns, specifically as it applies to dispensing and administration. I.e. specific priming volume, flushing, dwell time, etc. Do you have the same process for all patients or do you have unit/population specific practices (adult vs peds vs NICU)? Thanks!

We have been having increased reports from our cardiothoracic team with concerns about the potency of heparin we are using. I know this has come up before, but I am wondering if anyone else has been experiencing this or have done any potency testing? The manufacturers we have been getting concerns about are Hospira and Fresenius Kabi, 10,000 units/10L vials. Thanks

Hi All,

Our organization recently transitioned from Alaris to using CADD pumps for our PCA and PCEA infusions. The downside that we have been trying to work through is the lack of wireless connectivity in order to utilized pump interoperability. I was wondering if any of your organizations use CADD and are willing to provide insight on the wireless capabilities. We have not had the best of luck with the device company to troubleshoot this gap in safety.

Thank you,
Erica

I am reaching out to inquire if anyone has had hypoglycemia events (ie, <70) with long acting insulins (Semglee) vs. other insulins?

If you have, have you been able to identify the root cause(s) of the hypoglycemia with this med? What have you done to reduce the incidence? Hypoglycemia is multifactorial, but seem to see more with long acting insulins vs. any others.

Your feedback is appreciated!!

Hi,

We recently started tracking our scanning compliance for our pharmacy carousel. This is a metric recommended on the current ASHP Medication Safety Dashboard toolkit and they provide a benchmark of 95%.

Does anyone have a medication management policy/procedure for addressing patient's clinical needs (i.e. can't meet need by med administration before or after program hours) in recurring encounters/visits in behavioral health/intensive outpatient programs for children and adolescents? Do you permit use of patient's own medications (POM)? If yes, how do you have the approved POM medication order carry across the multiple encounters? I'm in an Epic organization. Thank you in advance.

I'm interested in any look/sound alike or high-alert meds at your hospitals that aren't on the ISMP lists. Maybe ones that you've identified based on your error reports, etc.

One that I've been thinking about lately is our epi nasal solution that looks just like an inj vial.

Thanks

Good morning,
Does your organization have a strategy for how many IV pumps you keep on hand?
How did you come up with your number?

We are frequently running low on LVPs (we use Alaris) and we are trying to see if there are best practices for how many we should have on hand per patient, or maybe average daily census?
Would love to hear how you handle at your organization.
Best,
Stacie Ethington MSN, RN
Nebraska Medicine

Has anyone else seen increased rates of infiltration with ampicillin IV push doses?
we recently switched to IV push antibiotics in light of the shortage and our L&D dept has reported infiltration occurring in their patients who are on ampicillin.

They are running it on a syringe pump.

Most manufacturers of antiretroviral medications prohibit repackaging. They state that the included desiccant in the bottle protects against moisture, but there is no evidence to support potency loss or degradation.

Most institutions repackage medications for inpatient use, and for outpatient care, educators assist patients in filling their pill bottles, which technically counts as repackaging.

Inquiring to learn What is the appropriate action to take in this scenario to ensure patient safety and compliance?

Any feedback is greatly appreciated. Thank you.